ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 102 out of 682

$1M Total Retail Price of All Prescriptions

Rank: 106 out of 682

648 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 648 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 648 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 16,111 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 681 597 1 2
LEVOTHYROXINE SODIUM 596 561 2 3
AMLODIPINE BESYLATE 561 489 3 6
METOPROLOL SUCCINATE 459 424 4 16
FUROSEMIDE 453 420 5 7
POTASSIUM CHLORIDE 433 413 6 14
HYDROCODONE-ACETAMINOPHEN 406 333 S3 7 1
PRAVASTATIN SODIUM 394 356 8 15
HYDROCHLOROTHIAZIDE 358 307 9 12
ATORVASTATIN CALCIUM 349 330 10 11
METOPROLOL TARTRATE 346 294 11 10
SIMVASTATIN 341 314 12 4
WARFARIN SODIUM 338 314 13 13
OMEPRAZOLE 315 287 14 5
TRIAMTERENE-HCTZ 297 257 15 57
PANTOPRAZOLE SODIUM 262 241 16 29
MELOXICAM 228 188 17 27
METFORMIN HCL 217 177 18 8
CLONIDINE HCL 213 190 19 48
CITALOPRAM HBR 202 182 20 17
LOSARTAN POTASSIUM 200 170 21 20
ZOLPIDEM TARTRATE 198 172 22 21
ALENDRONATE SODIUM 195 195 23 37
NEXIUM 190 179 24 19
TRAMADOL HCL 182 176 25 26
PAROXETINE HCL 181 176 26 53
ENALAPRIL MALEATE 178 168 27 91
CRESTOR 172 149 28 22
DIGOXIN 165 165 29 46
GLIPIZIDE ER 163 138 30 108
SPIRONOLACTONE 161 140 31 64
SYNTHROID 156 153 32 59
ATENOLOL 151 144 33 18
DONEPEZIL HCL 151 146 33 30
ISOSORBIDE MONONITRATE ER 149 130 35 31
TAMSULOSIN HCL 141 135 36 33
LANTUS 137 99 37 55
FELODIPINE ER 136 124 38 191
AMITRIPTYLINE HCL 132 107 R 39 50
RAMIPRIL 122 110 40 81
BUMETANIDE 120 115 41 115
GLIMEPIRIDE 116 108 42 43
CLOPIDOGREL 115 107 43 25
GABAPENTIN 114 105 44 9
FAMOTIDINE 108 108 45 99
PREDNISONE 108 101 45 40
ALLOPURINOL 105 101 47 32
AZITHROMYCIN 104 93 48 39
FLUTICASONE PROPIONATE 98 83 49 36
SERTRALINE HCL 98 72 49 24
CYCLOBENZAPRINE HCL 95 76 R 51 65
PLAVIX 91 87 52 35
NAMENDA 89 89 53 41
CELEBREX 82 69 54 80
INSULIN SYRINGE 80 61 55 75
POLYETHYLENE GLYCOL 3350 79 79 56 44
PREMARIN 79 72 R 56 132
TRIAMTERENE-HYDROCHLOROTHIAZID 79 79 56 174
LANTUS SOLOSTAR 78 74 59 114
CIPROFLOXACIN HCL 77 68 60 58
DIOVAN 76 74 61 42
FINASTERIDE 76 72 61 131
EVISTA 76 76 61 135
ESTRADIOL 74 41 R 64 152
CYMBALTA 74 65 64 51
LIPITOR 73 66 66 92
QUINAPRIL HCL 70 68 67 138
CARVEDILOL 67 61 68 23
ROPINIROLE HCL 66 56 69 71
MECLIZINE HCL 65 65 70 124
ZETIA 60 49 71 69
VYTORIN 59 55 72 145
ESCITALOPRAM OXALATE 59 58 72 73
TRAZODONE HCL 59 53 72 38
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 75 77
RANITIDINE HCL 56 48 76 28
TERAZOSIN HCL 54 54 77 171
ALPRAZOLAM 54 52 77 90
SUCRALFATE 53 41 79 160
COMBIVENT 52 50 80 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.